|By PR Newswire||
|September 27, 2012 05:02 AM EDT||
FREDERICK, Md., Sept. 27, 2012 /PRNewswire/ -- BioElectronics Corporation (BIEL), maker of consumer medical electronics products for pain management announced that Andrew J. Whelan, President, was featured on 'The Stock Radio' show about the Company's international expansion plans and the availability of ActiPatch® from Amazon.co.uk in Europe.
The interview is available at: http://thestockradio.com/andrew-whelan-of-bio-electronics-corp-otcpkbiel/1436
TheStockRadio.com is a small-cap research and investment commentary provider that strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. It provides investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on TheStockRadio please visit http://thestockradio.com
TheStockRadio.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. TheStockRadio.com is a Web site wholly owned by Allan James Group. TheStockRadio.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, TheStockRadio.com, for complete risks and disclosures. Contact: info@theStockRadio.com
About BioElectronics Corporation BioElectronics is an award winning developer and manufacturer of advanced consumer medical electronics. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for post-operative procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and accelerate healing. For more information, please visit www.bielcorp.com.
SOURCE BioElectronics Corporation